271 related articles for article (PubMed ID: 18199788)
1. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents.
Borman AM; Petch R; Linton CJ; Palmer MD; Bridge PD; Johnson EM
J Clin Microbiol; 2008 Mar; 46(3):933-8. PubMed ID: 18199788
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and characterization of Candida nivariensis from a culture collection of Candida glabrata clinical isolates in Malaysia.
Tay ST; Lotfalikhani A; Sabet NS; Ponnampalavanar S; Sulaiman S; Na SL; Ng KP
Mycopathologia; 2014 Oct; 178(3-4):307-14. PubMed ID: 25022264
[TBL] [Abstract][Full Text] [Related]
4. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil.
Ramos LS; Figueiredo-Carvalho MH; Barbedo LS; Ziccardi M; Chaves AL; Zancopé-Oliveira RM; Pinto MR; Sgarbi DB; Dornelas-Ribeiro M; Branquinha MH; Santos AL
J Antimicrob Chemother; 2015 Jan; 70(1):111-5. PubMed ID: 25134720
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Candida nivariensis and Candida bracarensis in vulvovaginal Candidiasis.
Li J; Shan Y; Fan S; Liu X
Mycopathologia; 2014 Oct; 178(3-4):279-83. PubMed ID: 25118875
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.
Arastehfar A; Daneshnia F; Salehi MR; Zarrinfar H; Khodavaisy S; Haas PJ; Roudbary M; Najafzadeh MJ; Zomorodian K; Charsizadeh A; Brouwer C; Pan W; Hagen F; Boekhout T
J Med Microbiol; 2019 May; 68(5):770-777. PubMed ID: 30924763
[TBL] [Abstract][Full Text] [Related]
7. First isolations in India of Candida nivariensis, a globally emerging opportunistic pathogen.
Chowdhary A; Randhawa HS; Khan ZU; Ahmad S; Juneja S; Sharma B; Roy P; Sundar G; Joseph L
Med Mycol; 2010 Mar; 48(2):416-20. PubMed ID: 19626545
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan.
Chen YC; Lin YH; Chen KW; Lii J; Teng HJ; Li SY
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):284-92. PubMed ID: 20851551
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Candida bracarensis and Candida nivariensis in a Spanish collection of yeasts: comparison of results from a reference centre and from a population-based surveillance study of candidemia.
Cuenca-Estrella M; Gomez-Lopez A; Isla G; Rodriguez D; Almirante B; Pahissa A; Rodriguez-Tudela JL;
Med Mycol; 2011 Jul; 49(5):525-9. PubMed ID: 21198347
[TBL] [Abstract][Full Text] [Related]
10. Candida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: First description of Candida nivariensis in Argentina.
Morales-López SE; Taverna CG; Bosco-Borgeat ME; Maldonado I; Vivot W; Szusz W; Garcia-Effron G; Córdoba SB
Mycopathologia; 2016 Dec; 181(11-12):871-878. PubMed ID: 27681573
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
12. Old and new pathogenic Nakaseomyces species: epidemiology, biology, identification, pathogenicity and antifungal resistance.
Angoulvant A; Guitard J; Hennequin C
FEMS Yeast Res; 2016 Mar; 16(2):fov114. PubMed ID: 26691882
[TBL] [Abstract][Full Text] [Related]
13. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
14. Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection.
Bishop JA; Chase N; Magill SS; Kurtzman CP; Fiandaca MJ; Merz WG
J Clin Microbiol; 2008 Feb; 46(2):443-6. PubMed ID: 18077641
[TBL] [Abstract][Full Text] [Related]
15. Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.
Sharma C; Wankhede S; Muralidhar S; Prakash A; Singh PK; Kathuria S; Kumar DA; Khan N; Randhawa HS; Meis JF; Chowdhary A
Diagn Microbiol Infect Dis; 2013 May; 76(1):46-50. PubMed ID: 23537782
[TBL] [Abstract][Full Text] [Related]
16. Lack of detection of Candida nivariensis and Candida bracarensis among 440 clinical Candida glabrata sensu lato isolates in Kuwait.
Asadzadeh M; Alanazi AF; Ahmad S; Al-Sweih N; Khan Z
PLoS One; 2019; 14(10):e0223920. PubMed ID: 31618264
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
[TBL] [Abstract][Full Text] [Related]
18. Candida nivariensis isolated from an Indonesian human immunodeficiency virus-infected patient suffering from oropharyngeal candidiasis.
Wahyuningsih R; SahBandar IN; Theelen B; Hagen F; Poot G; Meis JF; Rozalyani A; Sjam R; Widodo D; Djauzi S; Boekhout T
J Clin Microbiol; 2008 Jan; 46(1):388-91. PubMed ID: 18003796
[TBL] [Abstract][Full Text] [Related]
19. Candida nivariensis in comparison to different phenotypes of Candida glabrata.
Swoboda-Kopeć E; Sikora M; Golas M; Piskorska K; Gozdowski D; Netsvyetayeva I
Mycoses; 2014 Dec; 57(12):747-53. PubMed ID: 25267284
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of Candida glabrata, C. nivariensis and C. bracarensis based on fragment length polymorphism of ITS1 and ITS2 and restriction fragment length polymorphism of ITS and D1/D2 regions in rDNA.
Mirhendi H; Bruun B; Schønheyder HC; Christensen JJ; Fuursted K; Gahrn-Hansen B; Johansen HK; Nielsen L; Knudsen JD; Arendrup MC
Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1409-16. PubMed ID: 21607825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
